<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37712155</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0370-629X</ISSN><JournalIssue CitedMedium="Print"><Volume>78</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Revue medicale de Liege</Title><ISOAbbreviation>Rev Med Liege</ISOAbbreviation></Journal><ArticleTitle>[Long COVID, diagnosis and management : a survey among general practitioners in the Bas Rhin in France].</ArticleTitle><Pagination><StartPage>469</StartPage><EndPage>475</EndPage><MedlinePgn>469-475</MedlinePgn></Pagination><Abstract><AbstractText Label="UNLABELLED">The long COVID includes non-specific symptoms affecting patients of all ages.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Monocentric, prospective, quantitative and descriptive study interested in comparing the knowledge of general practitioners in Alsace (France) with the positioning and recommendations of the World Health Organisation (WHO) on long COVID in the period November 2022-February 2023. A multiple-choice questionnaire was elaborated based on the WHO positioning and recommendations on the long COVID.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">126 questionnaires were received, 65 (51.6 %) women, 42 % aged between 25-35 years. 84.9 % had knowledge about long COVID. The need for an impact on daily life, unexplained symptomatology and symptoms persisting at two months were criteria retained (84.9 %, 91.3 % and 82.5 %, respectively). A history of anxiety disorders (86.5 %) and severe acute forms of COVID-19 (57.9 %) were considered as risk factors. Fatigue, dyspnea, joint pain, headache and cough were associated with long COVID in 65.9 % of responders. About 74,6 % performed a complete blood test, 96.03 % recommended rehabilitation, 76.2 % referred to the pulmonologist and 71.4 % were in favour of a consensus document.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">General practitioners are aware of the existence of long COVID as a pathology and agree with the recommendations of scientific societies, among which those of WHO. However, this study has some limitations so that this topic deserves further dedicated investigations.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ambiehl</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine interne, H&#xf4;pitaux Universitaires de Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ambiehl</LastName><ForeName>Clement</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine interne, H&#xf4;pitaux Universitaires de Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Docquier</LastName><ForeName>L&#xe9;a</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine interne, H&#xf4;pitaux Universitaires de Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jannot</LastName><ForeName>Xavier</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine interne, H&#xf4;pitaux Universitaires de Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lorenzo-Villalba</LastName><ForeName>Noel</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine interne, H&#xf4;pitaux Universitaires de Strasbourg, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Face &#xe0; la COVID-19. COVID long, diagnostic et prise en charge : enqu&#xea;te aupr&#xe8;s de m&#xe9;decins g&#xe9;n&#xe9;ralistes du Bas Rhin en France.</VernacularTitle></Article><MedlineJournalInfo><Country>Belgium</Country><MedlineTA>Rev Med Liege</MedlineTA><NlmUniqueID>0404317</NlmUniqueID><ISSNLinking>0370-629X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058005" MajorTopicYN="Y">General Practitioners</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086742" MajorTopicYN="N">COVID-19 Testing</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="fre"><AbstractText>Le COVID long regroupe des sympt&#xf4;mes non sp&#xe9;cifiques affectant des patients de tous &#xe2;ges. M&#xe9;thodes : &#xc9;tude mono-centrique, prospective, quantitative et descriptive ayant pour but de confronter les connaissances des m&#xe9;decins g&#xe9;n&#xe9;ralistes d&#x2019;Alsace (France) au positionnement et aux recommandations de l&#x2019;Organisation Mondiale de la Sant&#xe9; (OMS) sur le COVID long. La p&#xe9;riode d&#x2019;&#xe9;tude s&#x2019;&#xe9;tend du 15 novembre 2022 au 15 f&#xe9;vrier 2023. Un questionnaire &#xe0; choix multiples est &#xe9;labor&#xe9; &#xe0; partir des recommandations de l&#x2019;OMS sur le COVID long. R&#xe9;sultats : 126 questionnaires analys&#xe9;s, 65 (51,6 %) femmes, 42 % des r&#xe9;pondants &#xe2;g&#xe9;s entre 25-35 ans. Globalement, 84,9 % des r&#xe9;pondants disent conna&#xee;tre le COVID long. La n&#xe9;cessit&#xe9; d&#x2019;un impact sur la vie quotidienne, la symptomatologie non expliqu&#xe9;e et sympt&#xf4;mes persistants &#xe0; 2 mois &#xe9;taient des crit&#xe8;res retenus (84,9 %, 91,3 % et 82,5 %, respectivement). Les ant&#xe9;c&#xe9;dents de troubles anxio-d&#xe9;pressifs (86,5 %) et les formes aigu&#xeb;s s&#xe9;v&#xe8;res (57,9 %) &#xe9;taient consid&#xe9;r&#xe9;s comme des facteurs de risque. La fatigue, la dyspn&#xe9;e, les douleurs articulaires, les c&#xe9;phal&#xe9;es et la toux sont associ&#xe9;es au COVID long dans 65,9 % des cas. Dans l&#x2019;ensemble, 74,6 % r&#xe9;alisent un bilan biologique complet, 96,03 % pr&#xe9;conisent la r&#xe9;&#xe9;ducation, 76,2 % orientent vers le pneumologue et 71,4 % &#xe9;taient favorables &#xe0; l&#x2019;&#xe9;laboration d&#x2019;un document de consensus. Conclusions : Les m&#xe9;decins g&#xe9;n&#xe9;ralistes interrog&#xe9;s connaissent l&#x2019;existence de cette pathologie et les d&#xe9;marches des r&#xe9;pondants sont en accord avec les recommandations des soci&#xe9;t&#xe9;s savantes, dont celles de l&#x2019;OMS. Cette &#xe9;tude comporte cependant diverses limitations et ce sujet m&#xe9;rite certainement des enqu&#xea;tes suppl&#xe9;mentaires.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">General practitioner</Keyword><Keyword MajorTopicYN="N">Questionnaire</Keyword><Keyword MajorTopicYN="N">Survey</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>18</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>4</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37712155</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>